Guardian Pharmacy Services Inc.
GRDN | NYSE
$44.16
-$0.83 (-1.84%)
At close: Sep 21, 2026, 4:00 PM ET
$44.16
$0 (0.00%)
After-hours:
Sep 21, 2026, 6:15 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 1.45B | 1.23B | 1.05B | 908.91M | 792.07M | 735.96M |
Cost of Revenue | 1.17B | 984.04M | 837.88M | 723.04M | 630.81M | 588.96M |
Gross Profit | 282.04M | 244.37M | 208.31M | 185.87M | 161.27M | 147M |
Operating Income | 88.91M | -62.92M | 40.95M | 51.99M | 30.15M | 32.06M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 73.42M | -66.48M | 37.72M | 49.66M | 28.33M | 29.66M |
Net Income | 49.22M | -87.29M | 23.9M | 35.42M | 16.31M | 19.94M |
Selling & General & Admin | 193.13M | 307.29M | 167.36M | 133.88M | 131.12M | 102.54M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | n/a | n/a | n/a | n/a | n/a | 12.4M |
Operating Expenses | 193.13M | 307.29M | 167.36M | 133.88M | 131.12M | 114.94M |
Interest Expense | 665K | 3.28M | 2.86M | 1.93M | 1.64M | 2.16M |
Selling & Marketing Expenses | n/a | n/a | n/a | 137.26M | 118.09M | 102.54M |
Cost & Expenses | 1.36B | 1.29B | 1.01B | 856.92M | 761.92M | 703.89M |
Income Tax Expense | 24.47M | 4.56M | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 62.39M | 62.01M | 60.84M | 60.84M | 60.84M | 60.84M |
Shares Outstanding (Diluted) | 63.3M | 62.01M | 60.84M | 60.84M | 60.84M | 60.84M |
EPS (Basic) | 0.79 | -1.77 | 0.39 | 0.58 | 0.27 | 0.33 |
EPS (Diluted) | 0.78 | -1.77 | 0.39 | 0.58 | 0.27 | 0.33 |
EBITDA | 96.42M | -43.43M | 58.81M | 68.15M | 46.49M | 49.07M |
EBIT | 74.09M | -63.2M | 40.58M | 51.59M | 29.96M | 31.82M |
Depreciation & Amortization | 22.34M | 19.77M | 18.23M | 16.56M | 16.53M | 17.26M |
Add to Watchlist
Select watchlists to add or remove GRDN